OTCMKTS:RBGLY - Reckitt Benckiser Group Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $91.00
  • Forecasted Upside: 502.25 %
  • Number of Analysts: 11
  • Breakdown:
  • 3 Sell Ratings
  • 1 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$15.11
▼ -0.19 (-1.24%)

This chart shows the closing price for RBGLY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Reckitt Benckiser Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RBGLY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RBGLY

Analyst Price Target is $91.00
▲ +502.25% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Reckitt Benckiser Group in the last 3 months. The average price target is $91.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 502.25% upside from the last price of $15.11.

This chart shows the closing price for RBGLY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in Reckitt Benckiser Group. This rating has held steady since March 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 8 buy ratings
  • 0 hold ratings
  • 3 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 3 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 3 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 3 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 3 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 3 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 3 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 3 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/24/2022BarclaysLower Price TargetGBX 9,300 ➝ GBX 8,600
5/18/2022Royal Bank of CanadaUpgradeSector Perform ➝ Outperform
5/3/2022BarclaysBoost Price TargetGBX 9,100 ➝ GBX 9,300
5/3/2022UBS GroupBoost Price TargetGBX 7,700 ➝ GBX 8,000
4/1/2022BarclaysBoost Price TargetGBX 88 ➝ GBX 91
3/23/2022Jefferies Financial GroupDowngradeHold ➝ Underperform
3/16/2022Societe GeneraleDowngradeBuy ➝ Sell
3/14/2022Exane BNP ParibasUpgradeUnderperform ➝ Neutral
3/14/2022Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
1/18/2022UBS GroupBoost Price TargetGBX 7,600 ➝ GBX 7,800
1/11/2022Exane BNP ParibasDowngradeNeutral ➝ UnderperformGBX 6,500
10/27/2021Royal Bank of CanadaReiterated RatingSector Perform
10/27/2021BarclaysReiterated RatingOverweight
10/1/2021UBS GroupReiterated RatingBuy
9/20/2021BarclaysReiterated RatingOverweight
8/11/2021Morgan StanleyReiterated RatingOverweight
8/2/2021Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
7/29/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
7/28/2021UBS GroupReiterated RatingBuy
7/28/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/28/2021Credit Suisse GroupReiterated RatingOutperform
7/28/2021BarclaysReiterated RatingOverweight
7/28/2021Royal Bank of CanadaReiterated RatingSector Perform
7/9/2021Royal Bank of CanadaReiterated RatingSector Perform
7/6/2021Sanford C. BernsteinDowngradeMarket Perform ➝ Underperform
7/1/2021Deutsche Bank AktiengesellschaftLower Price TargetBuyGBX 8,200 ➝ GBX 8,000
6/22/2021BarclaysReiterated RatingOverweight
6/4/2021Redburn PartnersUpgradeNeutral ➝ Buy
5/4/2021Societe GeneraleReiterated RatingBuy
4/30/2021BarclaysReiterated RatingOverweight
4/30/2021Berenberg BankReiterated RatingBuy
4/30/2021Morgan StanleyReiterated RatingOverweight
3/29/2021BarclaysReiterated RatingOverweight
3/4/2021Societe GeneraleUpgradeSell ➝ Buy
2/25/2021BarclaysReiterated RatingOverweight
2/25/2021Royal Bank of CanadaReiterated RatingSector Perform
2/25/2021Berenberg BankReiterated RatingBuy
2/25/2021Jefferies Financial GroupUpgradeUnderperform ➝ Hold
2/15/2021Sanford C. BernsteinUpgradeUnderperform ➝ Market Perform
2/8/2021Morgan StanleyReiterated RatingOverweight
1/13/2021BNP ParibasDowngradeOutperform ➝ Neutral
1/13/2021Exane BNP ParibasDowngradeOutperform ➝ Neutral
1/12/2021UBS GroupReiterated RatingBuy
12/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
11/19/2020Jefferies Financial GroupDowngradeHold ➝ Underperform
11/11/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform
11/6/2020Royal Bank of CanadaUpgradeUnderperform ➝ Sector Perform
10/23/2020Berenberg BankReiterated RatingBuy
10/21/2020UBS GroupReiterated RatingBuy
10/21/2020Societe GeneraleReiterated RatingSell
10/12/2020Sanford C. BernsteinInitiated CoverageUnderperform
9/30/2020BarclaysReiterated RatingOverweight
9/3/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
7/30/2020Berenberg BankReiterated RatingBuy
7/29/2020JPMorgan Chase & Co.Reiterated RatingOverweight
7/29/2020UBS GroupReiterated RatingBuy
7/29/2020BarclaysReiterated RatingOverweight
7/29/2020Royal Bank of CanadaReiterated RatingUnderperform
7/29/2020Credit Suisse GroupReiterated RatingNeutral
7/10/2020Berenberg BankReiterated RatingBuy
6/29/2020UBS GroupUpgradeNeutral ➝ Buy
6/26/2020JPMorgan Chase & Co.Reiterated RatingOverweight
6/23/2020BarclaysReiterated RatingOverweight
6/15/2020Morgan StanleyReiterated RatingOverweight
5/4/2020JPMorgan Chase & Co.Reiterated RatingOverweight
4/7/2020Morgan StanleyReiterated RatingOverweight
3/18/2020Jefferies Financial GroupUpgradeUnderperform ➝ Hold
10/16/2019Berenberg BankInitiated CoverageBuy
7/5/2019BNP ParibasReiterated RatingOutperform ➝ Neutral
7/2/2019Societe GeneraleDowngradeBuy ➝ Sell
6/28/2019HSBCInitiated CoverageBuy ➝ Buy
1/24/2019Jefferies Financial GroupDowngradeHold ➝ Underperform
11/20/2018BNP ParibasUpgradeNeutral ➝ Outperform
5/4/2018Credit Suisse GroupReiterated RatingNeutral ➝ Underperform
4/3/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy
3/23/2018Deutsche Bank AktiengesellschaftReiterated RatingBuy
3/22/2018Societe GeneraleUpgradeHold ➝ Buy
2/20/2018Credit Suisse GroupReiterated RatingOutperform ➝ Neutral
12/18/2017JPMorgan Chase & Co.Reiterated RatingBuy
9/7/2017JPMorgan Chase & Co.Reiterated RatingNeutral
9/5/2017BNP ParibasReiterated RatingOutperform ➝ Neutral
7/26/2017Kepler Capital MarketsDowngradeBuy ➝ Hold
7/6/2017Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 7/5/2017 forward)

News Sentiment Rating

-0.01 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/6/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
2/5/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
3/7/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/6/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
5/6/2022
  • 2 very positive mentions
  • 8 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
6/5/2022
  • 2 very positive mentions
  • 9 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
7/5/2022

Current Sentiment

  • 2 very positive mentions
  • 9 positive mentions
  • 5 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Reckitt Benckiser Group logo
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; sore throat medications; and hair removal products under the Nurofen, Strepsils, and Veet brands. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as analgesics, adult nutrition products, iron-fortified hypoallergenic baby formula, products for joint issues, and infant and toddler nutrition products, as well as vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, and Nutramigen brands. Further, it provides probiotics, sore throat pain relief products, Omega products, brain health support products, cleaning and carpet cleaning products, septic tank system treatment products, cough syrups, plant-based laundry products, probiotics, and lubricants under the Digestive Advantage, Cepacol, MegaRed, Neuriva, Easy-Off, RID-X, Delsym, Botanical Origin, Bodi-Ome, and K-Y brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
Read More

Today's Range

Now: $15.11
Low: $14.86
High: $15.11

50 Day Range

MA: $15.57
Low: $14.68
High: $16.42

52 Week Range

Now: $15.11
Low: $14.38
High: $18.55

Volume

473,323 shs

Average Volume

1,106,703 shs

Market Capitalization

$54.05 billion

P/E Ratio

N/A

Dividend Yield

3.01%

Beta

0.49

Frequently Asked Questions

What sell-side analysts currently cover shares of Reckitt Benckiser Group?

The following Wall Street sell-side analysts have issued stock ratings on Reckitt Benckiser Group in the last year: Barclays PLC, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Exane BNP Paribas, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Royal Bank of Canada, Sanford C. Bernstein, Societe Generale, and UBS Group AG.
View the latest analyst ratings for RBGLY.

What is the current price target for Reckitt Benckiser Group?

0 Wall Street analysts have set twelve-month price targets for Reckitt Benckiser Group in the last year. Their average twelve-month price target is $91.00, suggesting a possible upside of 502.3%.
View the latest price targets for RBGLY.

What is the current consensus analyst rating for Reckitt Benckiser Group?

Reckitt Benckiser Group currently has 3 sell ratings, 1 hold rating and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RBGLY, but not buy more shares or sell existing shares.
View the latest ratings for RBGLY.

How do I contact Reckitt Benckiser Group's investor relations team?

Reckitt Benckiser Group's physical mailing address is 103-105 BATH ROAD, SLOUGH X0, SL1 3UH. The company's listed phone number is 441753217800 and its investor relations email address is [email protected] The official website for Reckitt Benckiser Group is www.rb.com. Learn More about contacing Reckitt Benckiser Group investor relations.